About
Technology
Issues
FAQ
Links
Official Page
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.